Valuation VISEN Pharmaceuticals OTC Markets

Stocks

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

06-26	VISEN Pharmaceuticals Announces Board Appointments, Effective June 26, 2026	CI
05-17	VISEN Pharmaceuticals commences an Equity Buyback Plan for 11,392,686 shares, representing 10% of its issued share capital, under the authorization approved on June 27, 2025.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	3,095	1,866	-	-
Change	-	-39.73%	-	-
Enterprise Value (EV) ¹	2,640	1,603	1,866	2,006
Change	-	-39.26%	16.39%	7.48%
P/E	-12.1x	-18.3x	-30.7x	-
PBR	4.22x	3.76x	4.61x	17.5x
PEG	-0.5x	0.3x	0.8x	-
Capitalization / Revenue	18,761x	27.5x	4.17x	2.17x
EV / Revenue	15,999x	23.7x	4.17x	2.33x
EV / EBITDA	-12.1x	-6.64x	-11.1x	-12.2x
EV / EBIT	-12.7x	-6.53x	-10.9x	-31.5x
EV / FCF	-	-11.6x	-14.1x	-32.1x
FCF Yield	-	-8.64%	-7.08%	-3.11%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-2.44	-0.94	-0.56	-
Distribution rate	-	-	-	-
Net sales ¹	0.165	67.73	447.4	860.8
EBITDA ¹	-218	-241.4	-168.2	-164.1
EBIT ¹	-208.6	-245.7	-170.5	-63.6
Net income ¹	-253.4	-99	-58	-
Net Debt ¹	-455.7	-262.3	0.4861	140.2
Reference price ²	29.47	17.17	17.17	17.17
Nbr of stocks (in thousands)	105,021	109,035	-	-
Announcement Date	3/12/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	32.67x	5.84x	17.38x	0.98%	48B
REVOLUTION MEDICINES, INC.	-24.15x	363.29x	-22.19x	-.--%	41.13B
IQVIA HOLDINGS INC.	29.32x	2.95x	12.73x	-.--%	37.56B
BEONE MEDICINES AG	47.98x	4.87x	31.77x	-.--%	35.91B
CELLTRION, INC.	28.27x	8.18x	20.56x	0.41%	29.86B
MEDPACE HOLDINGS, INC.	32.7x	5.35x	24.3x	-.--%	16.05B
EUROFINS SCIENTIFIC SE	22.89x	2x	8.68x	1.16%	13.76B
ICON PUBLIC LIMITED COMPANY	26.61x	1.78x	10.95x	-.--%	12.1B
Average	24.54x	49.29x	13.02x	0.32%	29.3B
Weighted average by Cap.	23.06x	67.79x	11.93x	0.32%